ContraVir Pharmaceuticals, Inc. Sales Agreements
2 Contracts & Agreements
- Controlled Equity Offering Sales Agreement dated July 21, 2023 by and between Hepion Pharmaceuticals, Inc., and Cantor Fitzgerald & Co (Filed With SEC on July 21, 2023)
- At Market Issuance Sales Agreement, dated February 12, 2020, by and between Hepion Pharmaceuticals, Inc. and B. Riley FBR, Inc (Filed With SEC on February 12, 2020)